ENTRY       K08550                      KO
NAME        NR3A1, ESR1
DEFINITION  estrogen receptor alpha
PATHWAY     ko04915  Estrogen signaling pathway
            ko04917  Prolactin signaling pathway
            ko04919  Thyroid hormone signaling pathway
            ko04961  Endocrine and other factor-regulated calcium reabsorption
            ko05205  Proteoglycans in cancer
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Organismal Systems
              Endocrine system
               04915 Estrogen signaling pathway
                K08550  NR3A1, ESR1; estrogen receptor alpha
               04917 Prolactin signaling pathway
                K08550  NR3A1, ESR1; estrogen receptor alpha
               04919 Thyroid hormone signaling pathway
                K08550  NR3A1, ESR1; estrogen receptor alpha
              Excretory system
               04961 Endocrine and other factor-regulated calcium reabsorption
                K08550  NR3A1, ESR1; estrogen receptor alpha
             Human Diseases
              Cancers
               05205 Proteoglycans in cancer
                K08550  NR3A1, ESR1; estrogen receptor alpha
            Transcription factors [BR:ko03000]
             Eukaryotic Type
              Zinc finger
               Cys4 estrogen-like
                K08550  NR3A1, ESR1; estrogen receptor alpha
            Nuclear receptors [BR:ko03310]
             3. Estrogen like
              3A. Estrogen receptor
               K08550  NR3A1, ESR1; estrogen receptor alpha
DBLINKS     GO: 0030284
GENES       HSA: 2099(ESR1)
            PTR: 463079(ESR1)
            PPS: 100980011(ESR1)
            GGO: 101138953 101144112
            PON: 100441912(ESR1)
            MCC: 613025(ESR1)
            MCF: 102115223(ESR1)
            MMU: 13982(Esr1)
            RNO: 24890(Esr1)
            CGE: 100768474(Esr1)
            HGL: 101715977
            TUP: 102497715(ESR1)
            CFA: 403640(ESR1)
            AML: 100484518(ESR1)
            FCA: 552888(ESR1)
            PTG: 102969728(ESR1)
            BTA: 407238(ESR1)
            BOM: 102266924(ESR1)
            PHD: 102324116(ESR1)
            CHX: 102189484(ESR1)
            SSC: 397435(ESR1)
            CFR: 102519728(ESR1)
            BACU: 103009601(ESR1)
            LVE: 103069191(ESR1)
            ECB: 791249(ESR1)
            MYB: 102261068(ESR1)
            MYD: 102765890(ESR1)
            PALE: 102877910(ESR1)
            MDO: 100027187(ESR1)
            SHR: 100935401(ESR1)
            OAA: 100073581(ESR1)
            GGA: 396099(ESR1)
            MGP: 100542782
            TGU: 751998(ESR1)
            FAB: 101819288(ESR1)
            PHI: 102108976(ESR1)
            APLA: 101802318(ESR1)
            FPG: 101918191(ESR1)
            FCH: 102046059(ESR1)
            CLV: 102095459(ESR1)
            ASN: 102376369(ESR1)
            AMJ: 102564196(ESR1)
            PSS: 102456765(ESR1)
            CMY: 102934699(ESR1)
            ACS: 100337547(er)
            PBI: 103062891 103066127
            XLA: 398733(esr1-b) 398734(esr1-a)
            XTR: 394461(esr1)
            DRE: 259252(esr1)
            TRU: 101077800
            MZE: 101479381
            OLA: 101162413
            XMA: 102235986
            LCM: 102355896 102357490 102366323
            CMK: 103179230(esr1)
REFERENCE   PMID:21124311
  AUTHORS   Nilsson S, Gustafsson JA
  TITLE     Estrogen receptors: therapies targeted to receptor subtypes.
  JOURNAL   Clin Pharmacol Ther 89:44-55 (2011)
///
